Cargando…
Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting
AIM: Many pivotal trials in advanced hepatocellular carcinoma (HCC) require participants to have Child-Pugh A disease. However, many patients in real-world practice are Child-Pugh B or C. This study examined treatment patterns and clinical outcomes in patients with advanced HCC treated with first-li...
Autores principales: | Aly, Abdalla, Fulcher, Nicole, Seal, Brian, Pham, Trang, Wang, Yunfei, Paulson, Scott, He, Aiwu R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413176/ https://www.ncbi.nlm.nih.gov/pubmed/37577406 http://dx.doi.org/10.2217/hep-2023-0002 |
Ejemplares similares
-
The Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas
por: Choi, Tae Won, et al.
Publicado: (2015) -
Laparoscopic Cholecystectomy in Child-Pugh Class C Cirrhotic Patients
por: Currò, Giuseppe, et al.
Publicado: (2005) -
Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinoma
por: Sonohara, Fuminori, et al.
Publicado: (2018) -
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Xie, Enrui, et al.
Publicado: (2023) -
Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma
por: Cheon, Jaekyung, et al.
Publicado: (2023)